Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how treatment with evobrutinib reduced the size of inflammation-associated brain lesions in a Phase 2 trial in relapsing multiple sclerosis.Plus, Price reads the column by Jamie Hughes, A Life in Letters, “Being Prepared Can Help Us Succeed”.=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/